Prognostic Significance of the Preoperative Controlled Nutritional Status Score in Lung Cancer Patients Undergoing Surgical Resection

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65(1):5–29. doi:https://doi.org/10.3322/caac.21254
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N: Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489:519–525.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research N: Comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511:543–550.
   PubMed Web of Science ®Google Scholar
• Akamine T, Toyokawa G, Matsubara T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Shoji F, Okamoto T, et al. Significance of the preoperative CONUT score in predicting postoperative disease-free and overall survival in patients with lung adenocarcinoma with obstructive lung disease. Anticancer Res. 2017;37(5):2735–2742. doi:https://doi.org/10.21873/anticanres.11625
   PubMed Web of Science ®Google Scholar
• Park S, Ahn HJ, Yang M, Kim JA, Kim JK, Park SJ. The prognostic nutritional index and postoperative complications after curative lung cancer resection: A retrospective cohort study. J Thorac Cardiovasc Surg. 2020;160(1):276–285.
   PubMed Web of Science ®Google Scholar
• Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, Ikeya T, Muguruma K, Tanaka H, Toyokawa T, et al. Impact of the preoperative controlling nutritional status (CONUT) score on the survival after curative surgery for colorectal cancer. PLoS One. 2015;10(7):e0132488. doi:https://doi.org/10.1371/journal.pone.0132488
   PubMed Web of Science ®Google Scholar
• Yoshida N, Baba Y, Shigaki H, Harada K, Iwatsuki M, Kurashige J, Sakamoto Y, Miyamoto Y, Ishimoto T, Kosumi K, et al. Preoperative nutritional assessment by controlling nutritional status (CONUT) is useful to estimate postoperative morbidity after esophagectomy for esophageal cancer. World J Surg. 2016;40(8):1910–1917. doi:https://doi.org/10.1007/s00268-016-3549-3
   PubMed Web of Science ®Google Scholar
• Toyokawa T, Kubo N, Tamura T, Sakurai K, Amano R, Tanaka H, Muguruma K, Yashiro M, Hirakawa K, Ohira M, et al. The pretreatment controlling nutritional status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. BMC Cancer. 2016;16:722. doi:https://doi.org/10.1186/s12885-016-2696-0
   PubMed Web of Science ®Google Scholar
• Shoji F, Haratake N, Akamine T, Takamori S, Katsura M, Takada K, Toyokawa G, Okamoto T, Maehara Y. The preoperative controlling nutritional status score predicts survival after curative surgery in patients with pathological stage I non-small cell lung cancer. Anticancer Res. 2017;37(2):741–747.
   PubMed Web of Science ®Google Scholar
• Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, Haratake N, Akamine T, Hirai F, Tagawa T, et al. A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase. J Thorac Dis. 2019;11(3):927–935.
   PubMed Web of Science ®Google Scholar
• Joseph N, McWilliam A, Kennedy J, Haslett K, Mahil J, Gavarraju A, Mistry H, Van Herk M, Faivre-Finn C, Choudhury A, et al. Post-treatment lymphocytopaenia, integral body dose and overall survival in lung cancer patients treated with radical radiotherapy. Radiother Oncol. 2019;135:115–119.
   PubMed Web of Science ®Google Scholar
• Kuroda D, Sawayama H, Kurashige J, Iwatsuki M, Eto T, Tokunaga R, Kitano Y, Yamamura K, Ouchi M, Nakamura K, et al. Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. Gastric Cancer. 2018;21(2):204–212.
   PubMed Web of Science ®Google Scholar
• Miyake M, Morizawa Y, Hori S, Marugami N, Shimada K, Gotoh D, Tatsumi Y, Nakai Y, Inoue T, Anai S, et al. Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder. BMC Cancer. 2017;17(1):237.
   PubMed Web of Science ®Google Scholar
• Li W, Li M, Wang T, Ma G, Deng Y, Pu D, Liu Z, Wu Q, Liu X, Zhou Q, et al. Controlling nutritional status (CONUT) score is a prognostic factor in patients with resected breast cancer. Sci Rep. 2020;10(1):6633. doi:https://doi.org/10.1038/s41598-020-63610-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X. Controlling nutritional status score, a promising prognostic marker in patients with gastrointestinal cancers after surgery: a systematic review and meta-analysis. Int J Surg. 2018;55:39–45.
   PubMed Web of Science ®Google Scholar
• Takagi K, Domagala P, Polak WG, Buettner S, Ijzermans JNM. The controlling nutritional status score and postoperative complication risk in gastrointestinal and hepatopancreatobiliary surgical oncology: a systematic review and meta-analysis. Ann Nutr Metab. 2019;74(4):303–312.
   PubMed Web of Science ®Google Scholar
• Takagi K, Domagala P, Polak WG, Buettner S, Ijzermans JNM. Prognostic significance of the controlling nutritional status (CONUT) score in patients undergoing hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. BMC Gastroenterol. 2019;19(1):211.
   PubMed Web of Science ®Google Scholar
• Guo X, Shao J, Zhai B, Zou Q, Yan J, et al. Relationship and prognostic significance between preoperative serum albumin to globulin ratio and CT features of non-small cell lung cancer. Eur J Radiol. 2020;128:10939.
   Web of Science ®Google Scholar
• Ding N, Pang ZFei, Shen H, Ni Y, Du J, Liu Q. The prognostic value of PLR in lung cancer, a meta-analysis based on results from a large consecutive cohort. Sci Rep. 2016;6:34823. doi:https://doi.org/10.1038/srep34823
   PubMed Web of Science ®Google Scholar
• Lianyuan T, Dianrong X, Chunhui Y, Zhaolai M, Bin J. The predictive value and role of stromal tumor-infiltrating lymphocytes in pancreatic ductal adenocarcinoma (PDAC). Cancer Biol Ther. 2018;19(4):296–305.
   PubMed Web of Science ®Google Scholar
• Heinzel S, Marchingo JM, Horton MB, Hodgkin PD. The regulation of lymphocyte activation and proliferation. Curr Opin Immunol. 2018;51:32–38. doi:https://doi.org/10.1016/j.coi.2018.01.002
   PubMed Web of Science ®Google Scholar
• Toyokawa G, Shoji F, Yamazaki K, Shimokawa M, Takeo S. Significance of the red blood cell distribution width in resected pathologic stage I nonsmall cell lung cancer. Semin Thorac Cardiovasc Surg. 2019;S1043-0679:30134.
   Google Scholar
• Toyokawa G, Kozuma Y, Matsubara T, Haratake N, Takamori S, Akamine T, Takada K, Katsura M, Shimokawa M, Shoji F, et al. Prognostic impact of controlling nutritional status score in resected lung squamous cell carcinoma. J Thorac Dis. 2017;9(9):2942–2951. doi:https://doi.org/10.21037/jtd.2017.07.108
   PubMed Web of Science ®Google Scholar
• Shoji F, Miura N, Matsubara T, Akamine T, Kozuma Y, Haratake N, Takamori S, Katsura M, Takada K, Toyokawa G, et al. Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study. Interact Cardiovasc Thorac Surg. 2018;26(3):389–394. doi:https://doi.org/10.1093/icvts/ivx337
   PubMed Web of Science ®Google Scholar
• Miura N, Shoji F, Kozuma Y, Toyokawa G, Yamazaki K, Takeo S. Preoperative immune-nutritional abnormality predicts poor outcome in elderly non-small-Cell lung cancer patients with comorbidities. Ann Thorac Cardiovasc Surg. 2020;26(5):240–247. doi:https://doi.org/10.5761/atcs.oa.19-00207
   PubMed Web of Science ®Google Scholar
• Belanger MM, Gaudreau M, Roussel E, Couet J. Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells. Cancer Biol Ther. 2004;3(10):954–959. doi:https://doi.org/10.4161/cbt.3.10.1112
   PubMed Web of Science ®Google Scholar
• Krycer JR, Brown AJ. Cholesterol accumulation in prostate cancer: a classic observation from a modern perspective. Biochim Biophys Acta. 2013;1835(2):219–229. doi:https://doi.org/10.1016/j.bbcan.2013.01.002
   PubMed Web of Science ®Google Scholar
• Todor IN, Lukyanova NY, Chekhun VF. The lipid content of cisplatin- and doxorubicin-resistant MCF-7 human breast cancer cells. Exp Oncol. 2012;34(2):97–100.
   PubMedGoogle Scholar
• Li HY, Appelbaum FR, Willman CL, Zager RA, Banker DE. Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses. Blood. 2003;101(9):3628–3634. doi:https://doi.org/10.1182/blood-2002-07-2283
   PubMed Web of Science ®Google Scholar
• Jeon JH, Kim SK, Kim HJ, Chang J, Ahn CM, Chang YS. Lipid raft modulation inhibits NSCLC cell migration through delocalization of the focal adhesion complex. Lung Cancer. 2010;69(2):165–171. doi:https://doi.org/10.1016/j.lungcan.2009.10.014
   PubMed Web of Science ®Google Scholar
• Liu J, Xian G, Li M, Zhang Y, Yang M, Yu Y, Lv H, Xuan S, Lin Y, Gao L, et al. Cholesterol oxidase from bordetella species promotes irreversible cell apoptosis in lung adenocarcinoma by cholesterol oxidation. Cell Death Dis. 2014;5:e1372. doi:https://doi.org/10.1038/cddis.2014.324
   PubMed Web of Science ®Google Scholar
• Chi P-D, Liu W, Chen H, Zhang J-P, Lin Y, Zheng X, Liu W, Dai S. High-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma. PLoS One. 2014;9(3):e91080.
   PubMed Web of Science ®Google Scholar